Improving Outcomes in Schizophrenia-A Case for Initiation of Long-Acting Antipsychotics in Early-Phase Illness.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2022.24172
Abstract: The reduction of adverse outcomes is of crucial importance in schizophrenia, a relapsing and remitting chronic illness with a 13- to 15-year reduction in life expectancy. 1 The recurrence of acute psychotic symptoms after a… read more here.
Keywords: illness; long acting; laia treatment; risk ... See more keywords